Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 26, 2019
Improving HIV clinical trials with mobile technology
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Machine learning predicts HIV pseudovirus antibody neutralization
From the Gilbert group, Vaccine and Infectious Disease Division
Scientists strategize to stop HIV infections, work toward cure
A hot topic for a big scientific conference convening in Seattle
The interplay between antibodies and T cells in HIV risk
From the HVTN and Vaccine and Infectious Disease Division
Two is better than one
McElrath Laboratory, Vaccine and Infectious Disease Division
Training tomorrow's HIV researchers
With no end yet to the pandemic, a program supports young South African physician-scientists
Predicting a durable immune response
From HIV Vaccine Trails Network and Vaccine and Infectious Disease Division
With Fred Hutch's HIV lab in South Africa, 'We've become full partners.'
An HIV laboratory in South Africa advances scientific understanding, and more
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
On World AIDS Day, renewed hope for an HIV vaccine
Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’
Community is key for new, large HIV vaccine trial
Community trust is key as researchers start a new trial across 15 sites in South Africa
Good News: Dr. Oliver Press wins mentorship award; Seattle magazine names Dr. Larry Corey to Seattle's 'Hall of Fame'
Celebrating faculty and staff achievements
'Roz and Ray': An HIV tragedy with lessons for today
Seattle Repertory drama, panel explore fallout from an early AIDS crisis in hemophiliacs
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
AIDS 2016: Beyond HIV treatment to vaccines and a cure, calls to finish the job
Beyond HIV treatment to vaccines and a cure, calls to finish the job — and leave no one behind
Renewed hope at AIDS conference for halting HIV through vaccine
At International AIDS Conference, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection
International AIDS Conference: Where we’ve been, what’s next in the quest to end HIV
The last time the International AIDS Conference was in Africa, AIDS denialism was at its height; two Fred Hutch leaders in the fight to end HIV talk about where we’ve been – and what’s next
A virus researcher's 35 years in the AIDS trenches
After helping pave the way to HIV treatment, Dr. Larry Corey wants a vaccine — and a cure
Experimental HIV vaccine clinical trial to expand in South Africa
Scientists give go-ahead for what could become the first licensed vaccine against the AIDS virus
Beyond immunotherapy: Xconomy forum covers breadth of Seattle’s life sciences scene
Xconomy forum highlights research in vaccines, organ transplants, big data, more
Zika virus: 6 key things we don’t yet know
From lack of data to inconclusive blood tests to the unique challenges of pregnancy, experts weigh in on the knowledge gaps in this emerging infection
‘Don’t stop now’: an endgame for HIV/AIDS
HBO’s ‘Countdown to Zero,’ featuring Fred Hutch researchers, shows the pandemic remains, but fresh hope abounds